Gene selection in high-dimensional genomic data is crucial for understanding diseases and improving therapeutic outcomes.
Traditional feature selection methods often overlook biological pathways and regulatory networks, resulting in unstable and irrelevant gene signatures.
A new two-stage framework that combines statistical selection with biological pathway knowledge using multi-agent reinforcement learning (MARL) has been introduced.
Experiments on various gene expression datasets show that this approach enhances prediction accuracy and biological interpretability compared to conventional methods.